about
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...
Read More
25.74
1.49
(6.14%)
896.0K
XNAS Volume
XNAS 09 Jul, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
AnaptysBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..